Tetsu Maruyama, PhD, Chief Scientific Officer of the Dementia Discovery Fund (DDF) provides an overview of the current landscape in the diagnosis and treatment of dementia at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. Dr Maruyama discusses ongoing clinical trials in dementia but comments that there are currently no treatments which delay the disease progression.